The cost-effectiveness of a mechanical compression device in out-of-hospital cardiac arrest

TitreThe cost-effectiveness of a mechanical compression device in out-of-hospital cardiac arrest
Publication TypeJournal Article
Year of Publication2017
AuthorsMarti, J, Hulme, C, Ferreira, Z, Nikolova, S, Lall, R, Kaye, C, Smyth, M, Kelly, C, Quinn, T, Gates, S, Deakin, CD, Perkins, GD
JournalResuscitation
Volume117
Pagination1 - 7
Date Published08/2017
URLhttp://linkinghub.elsevier.com/retrieve/pii/S0300957217301983http://api.elsevier.com/content/article/PII:S0300957217301983?httpAccept=text/xmlhttp://api.elsevier.com/content/article/PII:S0300957217301983?httpAccept=text/plain
DOI10.1016/j.resuscitation.2017.04.036
ISSN0300-9572
Accession NumberPMID: 28476479
Mots-clésCardiac arrest, Cardiopulmonary Resuscitation/economics, Cardiopulmonary Resuscitation/methods, Cardiopulmonary Resuscitation/mortality, Case-Control Studies, Cost-Benefit Analysis, Cost-effectiveness, Emergency Medical Services/economics, Female, health economics, Heart Massage/economics, Heart Massage/instrumentation, Hospitalization/economics, Humans, Male, Mechanical compression, Middle Aged, Out-of-Hospital Cardiac Arrest/mortality, Out-of-Hospital Cardiac Arrest/therapy, Quality of Life, Quality-Adjusted Life Years, Surveys and Questionnaires, Treatment Outcome
Abstract

To assess the cost-effectiveness of LUCAS-2, a mechanical device for cardiopulmonary resuscitation (CPR) as compared to manual chest compressions in adults with non-traumatic, out-of-hospital cardiac arrest.
We analysed patient-level data from a large, pragmatic, multi-centre trial linked to administrative secondary care data from the Hospital Episode Statistics (HES) to measure healthcare resource use, costs and outcomes in both arms. A within-trial analysis using quality adjusted life years derived from the EQ-5D-3L was conducted at 12-month follow-up and results were extrapolated to the lifetime horizon using a decision-analytic model.
4471 patients were enrolled in the trial (1652 assigned to the LUCAS-2 group, 2819 assigned to the control group). At 12 months, 89 (5%) patients survived in the LUCAS-2 group and 175 (6%) survived in the manual CPR group. In the vast majority of analyses conducted, both within-trial and by extrapolation of the results over a lifetime horizon, manual CPR dominates LUCAS-2. In other words, patients in the LUCAS-2 group had poorer health outcomes (i.e. lower QALYs) and incurred higher health and social care costs.
Our study demonstrates that the use of the mechanical chest compression device LUCAS-2 represents poor value for money when compared to standard manual chest compression in out-of-hospital cardiac arrest.

WOS ID (UT)

000405399300014

Short TitleResuscitation
Citation Key / SERVAL ID8251
Peer reviewRefereed

                         

IUMSP | www.iumsp.ch
Institut universitaire de médecine sociale et préventive
Route de la Corniche 10, 1010 Lausanne - Switzerland
+41 21 314 72 72 | dess.info@unisante.ch

Go to top